SCILEX HOLDING COMPANY - COMMON STOCK

0,4526

08-января-25 16:45:00

15 мин. задержка

Акции

-0,0277

-5,77%

Сегодняшний диапазон

0,4328 - 0,4802

ISIN

N/A

Источник

NASDAQ

Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan

18 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)

12 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment Conference

09 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024

05 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination, Providing for a Pre-Transaction Equity Value of Semnur of $2.5 Billion

03 сен 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024

30 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label

29 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain

21 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa

09 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024

01 авг 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report

24 июл 2024 10:52:55 Источник Nasdaq GlobeNewswire
Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

23 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in Far East Region

17 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire
Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Enter into a Letter of Intent for a Proposed Business Combination

02 июл 2024 17:15:30 Источник Nasdaq GlobeNewswire
Scilex Holding Company to Ring Nasdaq Closing Bell on Friday, July 5th at 4:00PM ET at the Nasdaq MarketSite in Times Square, New York

02 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended June 30, 2024 and Second Quarter of 2024

01 июл 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

20 июн 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces Publication in PAIN Journal Regarding Phase 3 Results of the Pivotal Registration Trial of SP-102 (SEMDEXA™) in Lumbosacral Radicular Pain (Sciatica)

14 июн 2024 13:41:17 Источник Nasdaq GlobeNewswire
Scilex Holding Company to Present Poster on ELYXYB® (celecoxib oral solution) at the 66th Annual Scientific Meeting of the American Headache Society (AHS) to be Held in San Diego, CA on June 13-16, 2024

13 июн 2024 09:00:00 Источник Nasdaq GlobeNewswire
Scilex Holding Company Announces 5-Year Term of $100 Million Financing with Royalty-Based Payments and Potential Strategic Transactions with Perigrove and its Portfolio Companies

11 июн 2024 19:20:12 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.